AbD Serotec公司总部位于英国牛津附近的Kidlington，是2006年初由原来的Serotec、Antibodies by Design、Biogenesis和OBT四家公司合并而成，统一归德国著名的抗体公司MorphoSys旗下。AbD Serotec一如既往地恪守为客户提供高质量产品和高品质服务的承诺，生产基地Kidlington的生产线获得ISO9001认证，可以提供13000多种抗体、免疫学试剂，研发、服务基地德国慕尼黑附近Martinsried 的MorphoSys总部提供单抗制备和多种规模的抗体生产和标记服务。
MorphoSys
凭借其独特的HuCAL（the Human Combinatorial Antibody Library人组合抗体库）技术，MorphoSys正在发展用于疾病治疗和研究诊断目的的新生代抗体。众多合作伙伴包括制药和生物技术领域的知名公司，例如：德国的Bayer、Boehringer Ingelheim，Schering，Centocor/Johnson & Johnson，日本Daiichi Sankyo ，瑞士的Novartis、Roche，美国的Pfizer。
Antibodies by Design
2003年初，MorphoSys建立了Antibodies by Design公司，利用HuCAL技术为科研和诊断市场提供抗体定制服务，服务快速和抗体的高度特异性使其在学术和工业上都颇受推崇，已经开发了4000多种定制单克隆抗体。
Biogenesis
2005年1月MorphoSys 收购Biogenesis 集团（旗下包括英国普尔的Biogenesis有限责任公司和美国布伦特伍德的Biogenesis公司）作为把 HuCAL抗体带入到目录抗体市场的媒介。Biogenesis公司为MorphoSys带来超过20年的在抗体工业方面经验以及大量品种繁多的目录抗体。
Serotec
2006年1月，MorphoSys将Serotec公司纳入到其抗体研究部门，并且创立AbD Serotec商标。自20多年前建立以来，Serotec公司在研究用抗体以及抗体、客户服务的大型组合方面赢得了强有力的市场地位，其抗体产品在英、美、德、法和斯堪的纳维亚进行直销，另有超过55个国家的经销商。
(1323 pages, 8 MB zipped file)
Sections of Interest
(356 pages, 6 MB)
A-Z lists of our primary antibodies, secondary antibodies/reagents, negative isotype controls, and epitope tag and reporter protein antibodies
(112 pages, 2 MB)
Our comprehensive human, mouse, and rat CD marker range
(210 pages, 3.5 MB)
View our antibodies and kits for apoptosis and autophagy, the cell cycle, cellular structures, nuclear function, signal transduction and many other research areas
(94 pages, 1.5 MB)
Broken down by species, see the full list of antibodies and recombinant proteins we have available
(323 pages, 5 MB)
Includes our products for research in immune regulation and innate immunity
(38 pages, 1 MB)
Antibodies for research areas including development and repair, neurodegeneration and neurological disease, and neuron and glial markers
(88 pages, 1.5 MB)
View our endothelial, hematopoietic, mesenchymal, pluripotent and early differentiation stem cell antibody products
(10 pages, 200 kB)
(22 pages, 400 kB)
(24 pages, 500 kB)
(7 pages, 200 kB)
(2 pages, 39 kB)
(21 pages, 600 kB)
Includes our LYNX Rapid Antibody Conjugation Kits® and accessories for flow cytometry, ELISA and Western blotting
Oxford Biotechnology (OBT)
OBT公司是基于互联网的抗体销售公司，其客户遍布全球，于2006年1月被收购。OBT的产品组合现在也成为AbD Serotec 公司产品的一部分。
AbD (Antibodies Direct) is the research antibody division of MorphoSys, one of the world’s leading antibody technology companies.
The AbD Serotec brand was created in early 2006 to market the combined products and services of Antibodies by Design, Biogenesis, Serotec, and Oxford Biotechnology – more than 10,000 antibodies and immunological reagents, custom monoclonal antibodies developed from the MorphoSys HuCAL library, and large and small scale antibody production and conjugation services.
AbD Serotec prides itself on its commitment to providing its customers in research and industry the highest quality products and services, and has recently opened a new ISO 9001-certified production facility in Kidlington, near Oxford UK. This new facility is the AbD Serotec headquarters, and supports sales offices in Raleigh, North Carolina; Brentwood, New Hampshire; Duesseldorf, Germany; Paris, France; and Hamar, Norway. Custom monoclonal development services are performed at MorphoSys headquarters in Martinsried, near Munich in Germany.
MorphoSys
With its unique HuCAL technology (the Human Combinatorial Antibody Library) MorphoSys is developing the next generation of antibodies for treatment of disease and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Bayer, Boehringer Ingelheim, Centocor/Johnson & Johnson, Daiichi Sankyo, Novartis, Pfizer, Roche and Schering.
Antibodies by Design
In early 2003, MorphoSys established Antibodies by Design to provide custom antibody development services to the research and diagnostic markets using its proven HuCAL technology. The speed of this service and the high specificity of the antibodies proved extremely popular in both academia and industry, resulting in the development of more than 4000 custom monoclonal antibodies.
Biogenesis
MorphoSys acquired the Biogenesis group of companies (Biogenesis Ltd in Poole, UK, and Biogenesis Inc in Brentwood, NH, USA) in January 2005 as a vehicle to bring HuCAL antibodies into the catalog antibody market. Biogenesis brought more than 20 years experience in the antibody industry and a large and diverse range of catalog antibodies to the MorphoSys group.
Serotec
In January 2006, MorphoSys added Serotec to its Research Antibody Division, and created the AbD Serotec brand. Since its establishment more than 20 years ago, Serotec has earned a strong position in the global market for research antibodies with direct sales operations in the UK, USA, Germany, France, and Scandinavia, distributors in more than 55 countries, and a large portfolio of antibodies and custom services.
Oxford Biotechnology (OBT)
Acquired with Serotec in January 2006, OBT was an internet-based antibody sales company, with customers all over the world. The OBT product portfolio is now also part of the AbD Serotec offering.
